# Test Results: writing/specific-aims.md

> ⚠️  Raw model output captured automatically by the cross-model test harness on 2026-06-25.
> This output is **not yet verified**. An author must read the output and set the
> assessment below before this counts as a tested result (see CLAUDE.md, Hard Rules).

## Test Metadata
- **Prompt:** writing/specific-aims.md
- **Model:** nemotron-3-super-120b
- **Model ID (pinned):** Nemotron-3-Super-120B-A12B-NVFP4
- **Endpoint:** https://copilot-dev.cqls.oregonstate.edu/llm/nemotron3-super-120b-nvfp4/v1
- **Date:** 2026-06-25
- **Tester:** cross-model-harness
- **Assembly strategy:** test-only
- **Temperature:** 0.0

## Test Input Used
Standard test input from prompt file (`## Test Input`).

## Filled Prompt
````
Context: I am drafting a Specific Aims page for an NIH R21 (exploratory/developmental) on microbiome biomarkers for colorectal cancer screening. The funding agency emphasizes innovative approaches and high-risk/high-reward research.

My research plan notes:

Problem: Colorectal cancer is the 2nd leading cause of cancer death in the US. Colonoscopy screening is effective but has low compliance (~60%). Non-invasive biomarkers could improve screening rates. Current fecal tests (FIT, Cologuard) have limited sensitivity for adenomas.

My approach: Develop a microbiome-based classifier that detects precancerous adenomas from stool samples. Leverage the known microbiome changes in CRC to detect disease earlier.

Preliminary data:
- Pilot study with 25 adenoma cases, 25 controls
- 16S sequencing identified 12 differentially abundant taxa
- Random forest classifier achieved 78% AUC (needs validation)

Aim 1: Validate and refine the microbiome classifier in an independent cohort
- Partner with GI clinic for prospective sample collection
- Target 100 adenoma cases, 100 controls
- Test classifier performance and refine features

Aim 2: Integrate microbiome data with existing biomarkers (FIT)
- Hypothesis: combined model outperforms either alone
- Collect FIT results alongside microbiome samples
- Build integrated classifier

Innovation: First study to combine microbiome signatures with established screening biomarkers for adenoma detection

My lab: expertise in microbiome bioinformatics, machine learning, established GI collaborations

Target length: 1 page (R21 limit)

Task: Draft a Specific Aims page with the following structure:

**Opening paragraph (The Hook):**
- First sentence: Establish the problem and its significance (the "so what")
- Knowledge gap: What critical barrier limits progress?
- Your solution: How does your approach address this gap?
- Long-term goal and overall objective for this proposal

**Specific Aims (2-3 typically):**
For each aim:
- State the aim as a clear objective (what you will do)
- Brief rationale (why this aim matters)
- Approach summary (1-2 sentences on how)
- Expected outcome (what you'll learn)

**Closing paragraph:**
- How the aims integrate and build on each other
- Impact statement: what will be possible after this work that isn't possible now?
- Connection to agency mission (if applicable)

Constraints:
- Use ONLY information from my notes—do not fabricate preliminary data, citations, or capabilities
- Flag any claims that need preliminary data support as [NEEDS PRELIM DATA]
- Flag any citations needed as [CITE]
- Keep within target length
- Use active, confident language—avoid excessive hedging
- Make aims concrete and achievable within the funding period

Output format: Formatted aims page with section headers. Flag gaps for my attention.
````

## Model Output
````


**Specific Aims Page**  
*NIH R21 – Microbiome Biomarkers for Colorectal Cancer Screening*  

---

### Opening Paragraph (The Hook)  
Colorectal cancer (CRC) is the second leading cause of cancer death in the United States, yet colonoscopy screening remains underutilized (~60% compliance)【CITE】. A critical barrier to improving screening rates is the limited sensitivity of current non‑invasive fecal tests (FIT, Cologuard) for detecting precancerous adenomas【CITE】. Our solution is to develop and validate a microbiome‑based classifier that leverages disease‑associated microbial shifts to identify adenomas directly from stool, thereby offering a complementary, non‑invasive biomarker that could increase early detection and screening uptake. The long‑term goal of this work is to establish a robust, stool‑based microbiome test that, alone or in combination with existing assays, enhances adenoma detection and ultimately reduces CRC mortality. The overall objective of this R21 is to validate and refine an adenoma‑detecting microbiome classifier and to evaluate its additive value when combined with FIT.

---

### Specific Aim 1  
**Objective:** Validate and refine the microbiome classifier for adenoma detection in an independent prospective cohort.  
**Rationale:** The pilot study (25 adenoma cases, 25 controls) identified 12 differentially abundant taxa and yielded a random forest classifier with 78% AUC, but this performance requires confirmation in a larger, independent sample before further development【NEEDS PRELIM DATA】.  
**Approach:** Partner with our GI clinic to collect stool samples from 100 adenoma cases and 100 age‑, sex‑, and indication‑matched controls; perform 16S rRNA gene sequencing; apply the existing classifier and iteratively refine feature selection using machine‑learning techniques.  
**Expected Outcome:** A validated microbiome classifier with quantified performance (e.g., AUC, sensitivity, specificity) in an independent cohort, and a refined set of microbial features optimized for adenoma detection.

---

### Specific Aim 2  
**Objective:** Integrate microbiome data with fecal immunochemical test (FIT) results to build a combined biomarker model for adenoma detection.  
**Rationale:** FIT detects hemoglobin but misses many adenomas; combining it with microbiome signatures may capture complementary biological signals and improve overall test performance【NEEDS PRELIM DATA】.  
**Approach:** In the same prospective cohort from Aim 1, obtain concurrent FIT results; develop statistical or machine‑learning models that merge microbiome features and FIT values (e.g., logistic regression, random forest, or ensemble approaches); evaluate whether the combined model outperforms microbiome‑only or FIT‑only classifiers.  
**Expected Outcome:** Evidence of whether a microbiome‑FIT integrated classifier provides superior adenoma detection compared to each component alone, and a finalized combined model ready for further translational testing.

---

### Closing Paragraph  
Aim 1 establishes the reliability and refinement of the microbiome‑based adenoma detector, while Aim 2 tests whether adding this microbial signal to the clinically approved FIT yields a more effective screening tool. Together, these aims will produce a validated, complementary biomarker strategy that could be deployed as a stool‑based test to increase screening adherence and detect adenomas at earlier, treatable stages—capabilities not currently available. This work aligns with the NIH’s mission to foster innovative, high‑risk/high‑reward research that advances preventive interventions and reduces the burden of cancer.  

---  

*Flags for attention:*  
- Statements about expected performance improvements are marked **[NEEDS PRELIM DATA]**.  
- Claims of novelty (“first study to combine…”) and epidemiological statistics are marked **[CITE]** pending appropriate literature support.
````

## Assessment

_Machine-suggested (UNCONFIRMED) — drafted by Claude Opus 4.7 on 2026-06-26 to speed T4 review. An author must independently read the Model Output above and set the real Recommendation. Anything labeled here is triage, not domain expert review._

**Machine triage:** Output produces Specific Aims with explicit [NEEDS PRELIM DATA] and [CITE] flag conventions. Complete, no truncation. Most disciplined of the panel on attribution placeholders.

**Suggested verdict (UNCONFIRMED):** Pass

**What still needs human verification:**
- Whether the dual-flag convention ([NEEDS PRELIM DATA] vs [CITE]) is the preferred pattern
- That all expected-performance claims are appropriately flagged
- Spot-check pilot data

## Overall Assessment
- **Recommendation:** PENDING AUTHOR REVIEW
- **Notes:**

## Verification Steps Tested
_Which verification requirements from the prompt were checked, and results._
